Antimicrobial resistance profiles of ESKAPE and Escherichia coli isolated from blood at a tertiary hospital in China

Dan-Dan Wei,Jing Gao,Rui-Lin Yang,Chun-Yang Bai,Xu-Hong Lin
DOI: https://doi.org/10.1097/cm9.0000000000000987
IF: 6.133
2020-08-12
Chinese Medical Journal
Abstract:Bloodstream infections (BSIs) have emerged as a worldwide concern because of their increasing incidence, mortality, and associated healthcare cost. Strains in ESKAPE including <em>Enterococcus faecium</em> (<em>E. faecium</em>), <em>Staphylococcus aureus</em> (<em>S. aureus</em>), <em>Klebsiella pneumonia</em> (<em>K. pneumonia</em>), <em>Acinetobacter baumannii</em> (<em>A. baumannii</em>), <em>Pseudomonas aeruginosa</em> (<em>P. aeruginosa</em>), and <em>Enterobacter</em> spp., as well as <em>Escherichia coli</em> (<em>E. coli</em>), account for more than half of the causative pathogens of BSI.<sup><a class="ejp-citation-link js-ejp-citation-link">[1]</a></sup> Moreover, the incidences and resistance rates of ESKAPE and <em>E. coli</em> have changed in recent years. A study in Rome found that <em>E. coli</em>, followed by <em>S. aureus,</em> was the most frequently identified microorganism; further, the study revealed that, regardless of hospital or community-onset, the number of extended-spectrum β-lactamases-producing <em>E. coli</em> was increasing, and carbapenemase-producing <em>K. pneumoniae</em> had become more prevalent during the study period.<sup><a class="ejp-citation-link js-ejp-citation-link">[1]</a></sup> A recent study suggested upward resistance trends of ESKAPE and <em>E. coli</em> organisms isolated from blood cultures from 2014 to 2018 in a hospital in Italy.<sup><a class="ejp-citation-link js-ejp-citation-link">[2]</a></sup> The frequencies and resistance rates of ESKAPE and <em>E. coli</em> are most likely interrelated with the spectrum of disease, geographical situation, antimicrobial management, and hand hygiene. Since 2012, some requirements have been gradually executed according to the Measures for the Administration of Clinical Application of Antibiotics (Decree No. 84 of the Ministry of Health), the Guidelines for Clinical Application of Antibiotics (2015 edition), and the Notice on Continuous Management of Clinical Application of Antibiotics (General Office of the National Health Commission, 2018) at our hospital. However, it is unclear whether these measures are effective to minimize the antibiotic resistance rate. This study investigated the resistance rates and antimicrobial resistance indexes (ARIs) of ESKAPE and <em>E. coli</em> isolated from blood samples at our hospital, and aimed to contribute to the research on ESKAPE and <em>E. coli</em> in China as well as the availability of methods for antibiotic administration.
medicine, general & internal
What problem does this paper attempt to address?